What is NDC 69516-140?

69516-140 is the product NDC for Lynavoy (linerixibat), Linerixibat 40 mg/1 tablet, film coated, listed with the FDA by Intercept Pharmaceuticals Inc. It has 1 package NDC, shown above in 10- and 11-digit form.

Intercept Pharmaceuticals Inc, NDC labeler code 69516. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Lynavoy?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Lynavoy NDC 69516-140 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)69516-140Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69516-0140Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69516-140-60	69516014060	60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (69516-140-60)Marketed from Jun 11, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lynavoy
Generic name (nonproprietary): linerixibat
Active ingredients: Linerixibat — 40 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Intercept Pharmaceuticals IncNDC labeler code 69516
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 220295
Marketing start: Jun 11, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Ileal Bile Acid Transporter Inhibitors (Mechanism)
Identifiers: Product ID 69516-140_634f5ee8-336b-42a6-b481-db1c28bae053SPL ID 634f5ee8-336b-42a6-b481-db1c28bae053SPL set ID c00317c8-709c-4707-a6d1-632bff123026RxCUI 2745144, 2745150UNII 386012Z45SUPC 0369516140601
Pharmacologic class: Ileal Bile Acid Transporter Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469516014060 followed by a unit qualifier and the quantity

Package 69516-0140-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 29, 2026.

Indications (excerpt from the label)

LYNAVOY is indicated for the treatment of cholestatic pruritus associated with primary biliary cholangitis (PBC) in adult patients. Limitations of Use Avoid use of LYNAVOY in patients with decompensated cirrhosis or those with prior or active hepatic decompensation events (e.g. variceal hemorrhage, ascites, hepatic encephalopathy) [see Use in Specific Populations (8.7) , Clinical Pharmacology (12.3) ] . LYNAVOY is an ileal bile acid transporter (IBAT) inhibitor indicated for the treatment of cholestatic pruritus associated with primary biliary cholangitis (PBC) in adult patients. ( 1 ) Limitations of Use Avoid use of LYNAVOY in patients with decompensated cirrhosis or those with prior or act…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 69516-140

What is NDC 69516-140?: 69516-140 is the product NDC for Lynavoy (linerixibat), Linerixibat 40 mg/1 tablet, film coated, listed with the FDA by Intercept Pharmaceuticals Inc. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Lynavoy (Linerixibat).
What is the active ingredient?: Linerixibat.
Who is the labeler?: Intercept Pharmaceuticals Inc, NDC labeler code 69516. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Lynavoy?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Lynavoy (Linerixibat) NDC 69516-140